Supernus Pharmaceuticals reported $234.71M in Current Liabilities for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Adamas Pharmaceuticals ADMS:US 23.84M 2.02M
Aerie Pharmaceuticals AERI:US $ 118.13M 10.04M
Ani Pharmaceuticals ANIP:US $ 84.87M 4.58M
Aphria Inc APH:CN C$ 216.99M 75.99M
Aurora Cannabis Inc ACB:CN 120.39M 4.02M
Bristol Myers Squibb BMY:US $ 21460M 2469M
Canopy Growth Corp WEED:CN C$ 259.9M 3.77M
Cara Therapeutics CARA:US $ 15.53M 358K
Corcept Therapeutics CORT:US $ 44.76M 0.64M
Eisai 4523:JP Y 280829M 2895M
Eli Lilly And LLY:US $ 13682M 1411.2M
Endo International Ordinary Shares ENDP:US $ 1554.27M 145.06M
Gw Pharmaceuticals GWPH:US $ 160.25M 0.44M
Horizon Pharma HZNP:US $ 854.04M 1.23M
JAZZ PHA JAZZ:US $ 735.05M 145.54M
Lannett LCI:US $ 112.28M 21.81M
Marinus Pharmaceuticals MRNS:US $ 37.68M 20.98M
Pacira Pharmaceuticals PCRX:US $ 225.79M 2.9M
Perrigo Ordinary Shares PRGO:US $ 2003.8M 19.3M
Revance Therapeutics RVNC:US $ 65.87M 7.63M
Supernus Pharmaceuticals SUPN:US $ 234.71M 48.74M
Teva Pharmaceutical Industries TEVA:US $ 11825M 866M
United Therapeutics UTHR:US $ 320M 8.6M
Xeris Pharmaceuticals Inc XERS:US $ 37.28M 1.82M